SK18594A3 - Method of production of capsular polysacharide without lipid and endotoxine - Google Patents
Method of production of capsular polysacharide without lipid and endotoxine Download PDFInfo
- Publication number
- SK18594A3 SK18594A3 SK185-94A SK18594A SK18594A3 SK 18594 A3 SK18594 A3 SK 18594A3 SK 18594 A SK18594 A SK 18594A SK 18594 A3 SK18594 A3 SK 18594A3
- Authority
- SK
- Slovakia
- Prior art keywords
- prp
- ethanol
- phospholipase
- phenol
- lipid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- General Preparation And Processing Of Foods (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74652391A | 1991-08-16 | 1991-08-16 | |
| US07/909,346 US5314811A (en) | 1992-07-13 | 1992-07-13 | Process for converting lipid-containing bacterial capsular polysaccharide into lipid-free polysaccharide |
| PCT/US1992/006301 WO1993004183A1 (en) | 1991-08-16 | 1992-07-29 | Process for converting lipid-containing bacterial capsular polysaccharide into lipid-free polysaccharide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK18594A3 true SK18594A3 (en) | 1994-08-10 |
Family
ID=27114616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK185-94A SK18594A3 (en) | 1991-08-16 | 1992-07-29 | Method of production of capsular polysacharide without lipid and endotoxine |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0528635B1 (bg) |
| JP (1) | JPH05209002A (bg) |
| KR (1) | KR930004473A (bg) |
| CN (1) | CN1071699A (bg) |
| AT (1) | ATE176929T1 (bg) |
| AU (1) | AU2105492A (bg) |
| BG (1) | BG98470A (bg) |
| CA (1) | CA2075681C (bg) |
| CZ (1) | CZ28694A3 (bg) |
| DE (1) | DE69228454T2 (bg) |
| FI (1) | FI940700A (bg) |
| HU (1) | HU9400426D0 (bg) |
| IL (1) | IL102763A0 (bg) |
| MX (1) | MX9204721A (bg) |
| NZ (1) | NZ243892A (bg) |
| SK (1) | SK18594A3 (bg) |
| WO (1) | WO1993004183A1 (bg) |
| YU (1) | YU89692A (bg) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69731380T2 (de) * | 1996-02-14 | 2006-02-23 | Merck & Co., Inc. | Verfahren zur präzipitation von polysacchariden |
| US6410025B1 (en) | 1996-02-14 | 2002-06-25 | Merck & Co., Inc. | Polysaccharide precipitation process |
| SE0003958D0 (sv) | 2000-10-31 | 2000-10-31 | Biogaia Fermentation Ab | Method for growth of microorganisms |
| HU230490B1 (hu) | 2001-01-23 | 2016-08-29 | Sanofi Pasteur Inc. | Multivalens, meningokokkusz-eredetű poliszaccharid és fehérje konjugátumát tartalmazó vakcina |
| GB0115176D0 (en) * | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
| KR100826963B1 (ko) * | 2001-11-13 | 2008-05-02 | 주식회사 포스코 | 고로 노심온도 관리 방법 |
| GB0408978D0 (en) * | 2004-04-22 | 2004-05-26 | Chiron Srl | Meningococcal fermentation for preparing conjugate vaccines |
| EP2409995A3 (en) * | 2007-02-28 | 2012-08-15 | Lipoxen Technologies Limited | Reduction of endotoxin in polysialic acids |
| FR2918671B1 (fr) | 2007-07-10 | 2010-10-15 | Sanofi Pasteur | Milieu de culture d'haemophilus influenzae type b. |
| CN101724085B (zh) * | 2008-10-22 | 2011-09-21 | 上海生物制品研究所 | 一种荚膜多糖纯化方法 |
| CN103059149B (zh) * | 2011-10-19 | 2016-08-31 | 天士力制药集团股份有限公司 | 一种prp多糖提取方法 |
| CN102660602B (zh) * | 2012-04-17 | 2015-03-25 | 江苏康泰生物医学技术有限公司 | 快速纯化细菌荚膜多糖的方法 |
| CN102731670B (zh) * | 2012-06-29 | 2014-09-03 | 成都欧林生物科技股份有限公司 | Hib荚膜多糖纯化工艺 |
| MY182282A (en) * | 2015-05-04 | 2021-01-18 | Pfizer | Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof |
| BR102019021510A2 (pt) * | 2019-10-14 | 2022-01-25 | Instituto Butantan | Processo de produção, recuperação e purificação de polissacarídeo capsular poliribosil-ribitol-fosfato (prp) e uso do mesmo |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2316964A1 (fr) * | 1975-07-11 | 1977-02-04 | Pasteur Institut | Medicament contenant, a titre de principe actif, un produit a base de polysaccharides, notamment obtenu a partir de lipopolysaccharides bacteriens |
| NZ188211A (en) * | 1977-10-28 | 1984-09-28 | American Cyanamid Co | Isolation of polyribosyl ribitol phosphate(prp)from haemophilus influenzae type b;vaccine comprising prp and bordetellapertussis antigens |
-
1992
- 1992-07-29 HU HU9400426A patent/HU9400426D0/hu unknown
- 1992-07-29 WO PCT/US1992/006301 patent/WO1993004183A1/en not_active Application Discontinuation
- 1992-07-29 CZ CS94286A patent/CZ28694A3/cs unknown
- 1992-07-29 SK SK185-94A patent/SK18594A3/sk unknown
- 1992-08-10 NZ NZ243892A patent/NZ243892A/en unknown
- 1992-08-10 IL IL102763A patent/IL102763A0/xx unknown
- 1992-08-10 CA CA002075681A patent/CA2075681C/en not_active Expired - Fee Related
- 1992-08-12 AT AT92307395T patent/ATE176929T1/de not_active IP Right Cessation
- 1992-08-12 DE DE69228454T patent/DE69228454T2/de not_active Expired - Lifetime
- 1992-08-12 EP EP92307395A patent/EP0528635B1/en not_active Expired - Lifetime
- 1992-08-14 JP JP4217011A patent/JPH05209002A/ja active Pending
- 1992-08-14 KR KR1019920014649A patent/KR930004473A/ko not_active Application Discontinuation
- 1992-08-14 AU AU21054/92A patent/AU2105492A/en not_active Abandoned
- 1992-08-14 MX MX9204721A patent/MX9204721A/es unknown
- 1992-08-15 CN CN92110465A patent/CN1071699A/zh active Pending
- 1992-10-07 YU YU89692A patent/YU89692A/sh unknown
-
1994
- 1994-02-14 BG BG98470A patent/BG98470A/bg unknown
- 1994-02-15 FI FI940700A patent/FI940700A/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BG98470A (bg) | 1994-12-02 |
| EP0528635B1 (en) | 1999-02-24 |
| CN1071699A (zh) | 1993-05-05 |
| CZ28694A3 (en) | 1994-05-18 |
| AU2105492A (en) | 1993-02-18 |
| FI940700A0 (fi) | 1994-02-15 |
| YU89692A (sh) | 1995-10-24 |
| IL102763A0 (en) | 1993-01-31 |
| NZ243892A (en) | 1994-06-27 |
| HU9400426D0 (en) | 1994-05-30 |
| ATE176929T1 (de) | 1999-03-15 |
| WO1993004183A1 (en) | 1993-03-04 |
| DE69228454T2 (de) | 1999-07-15 |
| KR930004473A (ko) | 1993-03-22 |
| DE69228454D1 (de) | 1999-04-01 |
| MX9204721A (es) | 1993-07-01 |
| CA2075681C (en) | 2003-03-25 |
| JPH05209002A (ja) | 1993-08-20 |
| CA2075681A1 (en) | 1993-02-17 |
| EP0528635A1 (en) | 1993-02-24 |
| FI940700A (fi) | 1994-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7491517B2 (en) | Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135 | |
| SK18594A3 (en) | Method of production of capsular polysacharide without lipid and endotoxine | |
| JP6095715B2 (ja) | 二酸化炭素を用いて肺炎連鎖球菌（Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ）多糖の分子量を制御するための方法 | |
| KR910002704B1 (ko) | 폴리삭카라이드-단백질 결합체, 이의 제조방법 및 이를 함유하는 조성물 | |
| EP0035429B1 (fr) | Complexe vaccinal contenant un antigène spécifique et vaccin le contenant | |
| EP0302781B1 (fr) | Procédé d'obtention de polyosides capsulaires de staphylocoques, applications de ces polyosides et souches pour la mise en oeuvre du procédé | |
| JP2005532415A (ja) | スタフィロコッカス・アウレウスエキソポリサッカライド及び方法 | |
| WO1993007178A1 (fr) | Oligoside derive d'un polyoside antigenique issu d'un agent pathogene | |
| CS244906B2 (en) | Production method of antigen agent for limitation or prevention of tooth defects | |
| ZA200307238B (en) | Methods for the production of 3-o-deactivated-4-monophosphoryl lipid a(3d-mla) | |
| EP0407037B1 (en) | Process for removing bacterial endotoxin from gram-negative polysaccharides | |
| IE51174B1 (en) | Group b streptococcal capsular polysaccharides | |
| Cummins | Some observations on the nature of the antigens in the cell wall of Corynebacterium diphtheriae | |
| EP0179679B1 (fr) | Polysaccharides membranaires utiles notamment comme médicament et procédé pour leur préparation | |
| KR940010861B1 (ko) | 세포연관 글루코실트랜스퍼라제, 그의 항체 및 유효성분으로서 상기 항체를 함유하는 이의 카리에스 예방 조성물 | |
| US3636192A (en) | Meningococcal polysaccharide vaccines | |
| US5314811A (en) | Process for converting lipid-containing bacterial capsular polysaccharide into lipid-free polysaccharide | |
| Reed | Chemical and antigenic properties of the cell wall of Actinomyces viscosus (Strain T6) | |
| EP0298991B1 (en) | Novel lectins derived from bacterial pili | |
| Mizushiri et al. | Chemical characterization of lipopolysaccharides from Proteus strains used in Weil-Felix test | |
| WO1991018104A1 (en) | Indh enzyme compositions and their methods of use | |
| RU2407792C1 (ru) | СПОСОБ ПОЛУЧЕНИЯ IgAl-ПРОТЕАЗЫ ИЗ КУЛЬТУРЫ NEISSERIA MENINGITIDIS СЕРОГРУППЫ А И ИММУНОГЕННЫЙ ПРЕПАРАТ НА ЕЕ ОСНОВЕ | |
| JP3747077B2 (ja) | 百日咳菌由来感染防御成分の分離取得方法 | |
| JP2598802B2 (ja) | 菌体結合型グルコシルトランスフェラーゼ | |
| JPH0192201A (ja) | Ｄ．２５の新規な誘導体とその製造法、並びに免疫刺激物としての利用と本誘導体を含有した薬剤組成物 |